v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jul. 31, 2021
Jul. 31, 2020
Operating activities    
Net loss $ (140,189) $ (49,096)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 24,725 17,621
Loss on disposal of fixed assets 244 0
Amortization of intangible assets 5,735 207
Amortization of deferred contract acquisition costs 50,419 28,171
Non-cash operating lease cost 4,469 4,939
Provision for credit losses 354 (269)
Stock-based compensation expense 130,649 61,351
Gain on sale of debt securities, net 0 (1,347)
Accretion of marketable securities purchased at a premium 0 578
Non-cash interest expense 1,199 320
Change in fair value of strategic investments (4,356) 0
Changes in operating assets and liabilities, net of impact of acquisition    
Accounts receivable (24,257) 16,020
Deferred contract acquisition costs (87,576) (48,988)
Prepaid expenses and other assets (47,883) (1,953)
Accounts payable 5,383 9,634
Accrued expenses and other current liabilities 55,242 (8,112)
Accrued payroll and benefits 22,853 (711)
Operating lease liabilities (5,022) 1,315
Deferred revenue 251,742 118,672
Other liabilities 12,277 5,250
Net cash provided by operating activities 256,008 153,602
Investing activities    
Purchases of property and equipment (55,793) (30,334)
Capitalized internal-use software and website development (9,273) (3,850)
Purchase of strategic investments (7,309) (1,000)
Business acquisition, net of cash acquired (353,746) 0
Purchases of marketable securities 0 (84,904)
Proceeds from sales of marketable securities 0 639,586
Maturities of marketable securities 0 91,605
Net cash (used in) provided by investing activities (426,121) 611,103
Financing activities    
Proceeds from issuance of common stock upon exercise of stock options 9,492 16,601
Proceeds from issuance of common stock under the employee stock purchase plan 27,452 17,284
Capital contributions from non-controlling interest holders 3,655 550
Net cash provided by financing activities 38,799 34,435
Effect of foreign exchange rates on cash and cash equivalents (243) 796
Net (decrease) increase in cash and cash equivalents (131,557) 799,936
Cash and cash equivalents, beginning of period 1,918,608 264,798
Cash and cash equivalents, end of period 1,787,051 1,064,734
Supplemental disclosure of cash flow information:    
Interest paid 78 0
Income taxes paid, net of refunds received 2,337 663
Supplemental disclosure of non-cash investing and financing activities:    
Net increase (decrease) in property and equipment included in accounts payable and accrued expenses 4,480 (1,020)
Vesting of early exercised stock options 1,594 1,722
Equity consideration for acquisitions 4,011 0
Operating lease liabilities arising from obtaining operating right of-use assets 3,121 0
Line of Credit    
Financing activities    
Payment of debt issuance costs (219) 0
Senior Notes    
Financing activities    
Payment of debt issuance costs $ (1,581) $ 0